Rankings
▼
Calendar
SRPT Q1 2024 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$413M
+63.1% YoY
Gross Profit
$363M
87.8% margin
Operating Income
$35M
8.4% margin
Net Income
$36M
8.7% margin
EPS (Diluted)
$0.37
QoQ Revenue Growth
+4.2%
Cash Flow
Operating Cash Flow
-$242M
Free Cash Flow
-$285M
Stock-Based Comp.
$41M
Balance Sheet
Total Assets
$3.2B
Total Liabilities
$2.3B
Stockholders' Equity
$961M
Cash & Equivalents
$427M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$413M
$254M
+63.1%
Gross Profit
$363M
$218M
+66.1%
Operating Income
$35M
-$138M
+125.3%
Net Income
$36M
-$517M
+107.0%
Geographic Segments
UNITED STATES
$190M
84%
Rest of World
$36M
16%
← FY 2024
All Quarters
Q2 2024 →